Clement Leong

Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia.

Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia.

SciVentures Investments Pty Ltd (SciVentures Investments) is a venture capital subsidiary of Government of Australia founded in 2002 by Gregory R. Smith, Ross Chessari and David James. The firm is headquartered in Victoria, Australia.

4G Vaccines Pty Ltd. commercializes vaccine technologies. The firm provides immunotherapeutic treatment for breast cancer focused on two key innovations-use of mimic peptides and a potent cell-mediated stimulating adjuvant with potential use in other cancers. The company is headquartered in Heidelberg, Australia.

Glutagen Pty Ltd. develops enzyme therapies for the treatment of gluten intolerance and coeliac disease. The company has two products Glutazyme and Glutaren. The company was founded by Teodor Stelmasiak in 2001 and is headquartered in South Melbourne, Australia.

Medsaic Pty Ltd. commercializes a platform technology based on a protein microarray for the diagnosis of disease through the identification of patterns of antigen expression on cells. The company was founded in 2000 and is headquartered in Victoria, Australia.